Obesity Clinical Trial
Official title:
The Effect of Incorporating Soy Protein Foods in the Colorado Diet for Weight Loss and Maintenance
| NCT number | NCT02380963 |
| Other study ID # | 1152341 |
| Secondary ID | |
| Status | Completed |
| Phase | N/A |
| First received | |
| Last updated | |
| Start date | February 2015 |
| Est. completion date | November 2016 |
| Verified date | October 2019 |
| Source | DuPont Nutrition and Health |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
Dietary protein is a key element of most effective weight loss regimens. This study will investigate the effects of consuming soy protein on body composition and cardiometabolic health within the context of an effective weight loss and maintenance program called the Colorado Diet.
| Status | Completed |
| Enrollment | 72 |
| Est. completion date | November 2016 |
| Est. primary completion date | October 2016 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 18 Years to 55 Years |
| Eligibility |
Inclusion Criteria: - BMI between 27-40 - Weight stable (have not lost or gained more than 10 pounds in the last 3 months) - Generally healthy - Able to exercise 70 minutes per day at moderate intensity - Willing and able to participate in a State of Slim group class for the first 16 weeks of the study and willing to participate in 5 study visits over the 12 month study period. Exclusion Criteria: - Pregnant or trying to become pregnant. - Diagnosis of type 1 or type 2 diabetes - Individuals following a vegetarian only diet - Food allergies (to soy, dairy, wheat/gluten, or peanut) - Taking medications that could cause weight loss or weight gain or alter plasma lipids (such as steroids, tricyclic antidepressants, chemotherapy, antipsychotics, prescribed or OTC weight loss agents, statins, fibrates, niacin, etc). Oral contraceptives can be used as long as subject agrees to not change use of these during the study. - Known renal disease - Clinical hypothyroidism - Current alcohol or drug abuse or dependence (Subjects who have quit smoking in the last 6 months will be excluded. Smokers whose smoking habits have been stable for the last 6 months and which remain stable during the study can be included). - Any medical condition for which following a diet and/or 70 minutes of exercise daily would be inadvisable - LDL cholesterol levels above 190 mg/dl or triglycerides above 400 mg/dl. |
| Country | Name | City | State |
|---|---|---|---|
| United States | Anschutz Health and Wellness Center, University of Colorado | Aurora | Colorado |
| Lead Sponsor | Collaborator |
|---|---|
| DuPont Nutrition and Health | University of Colorado, Denver |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Body weight & body composition | Changes in skeletal muscle mass and fat mass will be measured using dual-energy X-ray absorptiometry (DXA) | 0, 2, 4, 8, 12 mths | |
| Secondary | Blood lipid and lipoproteins | Changes in lipids and lipoproteins will be measured using the Vertical Auto Profile (VAP) Test | 0, 2, 4, 8, 12 mths | |
| Secondary | C-reactive protein | Changes in inflammatory status will be assessed by measuring circulating c-reactive protein | 0, 2, 4, 8, 12 mths | |
| Secondary | Level of Fitness | Changes in the level of fitness will be measured by a 3 minute step test, grip strength, and flexibility testing. | 0, 12 mths | |
| Secondary | Quality of Life | Changes in the quality of life will be measured via Wellness Assessment Questionnaire | 0, 4, 8, 12 mths |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
| Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
| Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
| Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
| Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
| Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
| Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
| Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
| Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
| Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
| Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
| Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
| Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
| Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
| Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
| Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
| Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |